PRaG5.0 combined with chemotherapy and sequential chemoimmunotherapy for massive SMARCA4-deficient undifferentiated tumor of the cervix: case report
SMARCA4-deficient undifferentiated cervical tumor is highly malignant and responds poorly to conventional treatments, leading to a very poor prognosis. We report a case involving a primary cervical lesion measuring 9.8 cm, managed using a strategy of “…